PSORIASIS VULGARIS
Clinical trials for PSORIASIS VULGARIS explained in plain language.
Never miss a new study
Get alerted when new PSORIASIS VULGARIS trials appear
Sign up with your email to follow new studies for PSORIASIS VULGARIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Light-Activated gel shows promise for psoriasis in early trial
Disease control CompletedThis study tested a gel called SGX302 (synthetic hypericin) combined with visible light to treat mild-to-moderate psoriasis. 15 adults with plaque psoriasis applied the gel to their skin and received light therapy over 18 weeks. The goal was to see if the treatment could clear or…
Matched conditions: PSORIASIS VULGARIS
Phase: PHASE2 • Sponsor: Soligenix • Aim: Disease control
Last updated May 17, 2026 02:14 UTC
-
Psoriasis patients may cut drug doses without Flare-Ups, study finds
Disease control CompletedThis study tested whether people with stable psoriasis could safely reduce their dose of IL17 or IL23 inhibitor drugs without causing flare-ups. 244 adults with well-controlled psoriasis were randomly assigned to either dose reduction or standard care. The goal was to see if lowe…
Matched conditions: PSORIASIS VULGARIS
Phase: PHASE4 • Sponsor: Radboud University Medical Center • Aim: Disease control
Last updated May 17, 2026 02:02 UTC
-
Heavier psoriasis patients may need stronger dose, new study suggests
Disease control CompletedThis study tested whether a higher dose of the drug brodalumab works better than the standard dose for people with moderate-to-severe plaque psoriasis who weigh over 120 kg. About 385 participants received either the adjusted or standard dose for 52 weeks. The goal was to see if …
Matched conditions: PSORIASIS VULGARIS
Phase: PHASE4 • Sponsor: LEO Pharma • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
Could a plant extract cream soothe psoriasis? new trial tests it
Symptom relief CompletedThis study tested a cream made from plant compounds called total coumarins in 88 adults with mild-to-moderate psoriasis. Participants applied the cream or a placebo for several weeks. Researchers measured how much the skin cleared and checked for side effects. The goal was to see…
Matched conditions: PSORIASIS VULGARIS
Phase: PHASE2 • Sponsor: Psoriasis Research Institute of Guangzhou • Aim: Symptom relief
Last updated Apr 29, 2026 15:15 UTC